Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
Clinical trial NCT04324372 · COMPLETED
Trial details
- NCT number
- NCT04324372
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2021-02-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.